Related Experiment Video

Updated: Jan 25, 2026

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation
09:53

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation

Published on: January 10, 2025

824

Inhibition of fibronectin polymerization alleviates kidney injury due to ischemia-reperfusion

Stephanie L K Bowers1,2, Stephanie Davis-Rodriguez1,2,3, Zachary M Thomas1,2

  • 1Department of Pediatrics, University of Cincinnati College of Medicine , Cincinnati, Ohio.

American Journal of Physiology. Renal Physiology
|April 25, 2019
PubMed

Insights

A peptide called pUR4 effectively reduces kidney fibrosis and tissue damage after injury. This finding suggests inhibiting matrix polymerization is a promising strategy for treating kidney disease.

Area of Science:

  • Nephrology
  • Biomedical Engineering
  • Regenerative Medicine

Background:

  • Fibrosis is a hallmark of chronic kidney disease (CKD) progression.
  • Current therapies do not effectively halt or reverse renal fibrosis.
  • Fibronectin polymerization plays a critical role in fibrotic tissue remodeling.

Purpose of the Study:

  • To investigate the efficacy of the peptide pUR4 in mitigating renal fibrosis.
  • To evaluate pUR4's impact on tissue remodeling in a preclinical model of kidney injury.
  • To explore novel therapeutic strategies targeting matrix polymerization in kidney disease.

Main Methods:

  • Utilized a clinically relevant model of unilateral ischemia-reperfusion injury in the kidney.
  • Administered the small peptide pUR4 to assess its antifibrotic effects.
  • Analyzed renal tissue for markers of fibrosis and remodeling.

Main Results:

  • pUR4 significantly decreased renal fibrosis following ischemia-reperfusion injury.
  • The peptide treatment attenuated adverse tissue remodeling in the injured kidneys.
  • Results demonstrate pUR4's effectiveness in a relevant disease model.

Conclusions:

  • Inhibition of fibronectin polymerization with pUR4 offers a potential therapeutic approach for kidney injury.
  • Targeting matrix polymerization represents a novel strategy to combat renal fibrosis.
  • pUR4 may be beneficial as a standalone therapy or in combination with other treatments for ischemic kidney injury.
Keywords:
acute kidney injurychronic kidney diseasefibronectinfibrosisischemia-reperfusion

More Related Videos

Ischemia-reperfusion Model of Acute Kidney Injury and Post Injury Fibrosis in Mice09:09

Ischemia-reperfusion Model of Acute Kidney Injury and Post Injury Fibrosis in Mice

Published on: August 9, 2013

40.8K
Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research03:13

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research

Published on: November 3, 2023

2.9K

Related Concept Videos

Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
642
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
982
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
426
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
314
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.0K
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
863